ACTRN12605000682640招募中不适用
A single-arm, open-label, multi-centre pilot study evaluating the efficacy and safety of Ro 25-8310 combination therapy with Ro 20-9963 in pateints with chronic hepatitis C attending a methdone clinic
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- All
入选标准
- •Serological evidence of chronic hepatitis C infection by an anti-HCV antibody test for > 6 months; Detectable serum HCV-RNA; elevated serum ALT activity documented on at least two occasions at least one month apart withinthe last 6 months; liver biopsy findings consistant with the diagnosis of chronic hepatitis C infection with or without compensated cirrhosis; compensated liver disease; have had an episode of injecting drug use with 6 months of screening; on a recognized pharmacotherapy detoxification program such as Methadone, Buprenorhine, or Naltrexone.
排除标准
- •Positive test at screening for anti-HAV IgM Ab, HBsAg, anti-HBc IgM Ab, anti-HIV Ab; History of other medical condition associated with chronic liver disease other than HCV.
研究者
相似试验
招募中
1 期
Study to evaluate Pegcetacoplan in patients with TA-TMA after hematopoietic stem cell transplantatioTransplant-associated Thrombotic Microangiopathy (TA TMA)MedDRA version: 20.0Level: PTClassification code: 10043645Term: Thrombotic microangiopathy Class: 100000004851CTIS2023-510443-37-00Swedish Orphan Biovitrum AB (publ)12
进行中（未招募）
1 期
An Open-label, Single-arm, Multicenter Pilot Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Pegcetacoplan in Patients with Transplant-associated Thrombotic Microangiopathy (TA-TMA) After Hematopoietic Stem Cell Transplantation (HSCT)Transplant-Associated Thrombotic Microangiopathy (TA-TMA)MedDRA version: 20.0Level: PTClassification code 10043645Term: Thrombotic microangiopathySystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2021-003157-27-ESSwedish Orphan Biovitrum AB9
进行中（未招募）
1 期
An Open-label, Single-arm, Study to Evaluate Pegcetacoplan in Patients with TA-TMA after HSCTTransplant-Associated Thrombotic Microangiopathy (TA-TMA)MedDRA version: 20.0Level: PTClassification code 10043645Term: Thrombotic microangiopathySystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2021-003157-27-GRSwedish Orphan Biovitrum AB9
进行中（未招募）
1 期
A multicenter study to evaluate the safety, distribution , metabolism, elimination and pharmacological action of Pegcetacoplan in patients that experienced Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation (HSCT)',EUCTR2021-003157-27-ITSWEDISH ORPHAN BIOVITRUM AB (PUBL)9
进行中（未招募）
1 期
A study to evaluate the effect of ALN-PCSSC treatment in patients with Homozygous Familial HypercholesterolemiaMedDRA version: 19.1Level: LLTClassification code 10057080Term: Homozygous familial hypercholesterolemiaSystem Organ Class: 100000004850Homozygous Familial HypercholesterolemiaEUCTR2016-003376-49-NLThe Medicines Company10